Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Med Decis Making. 2018 Apr;38(1 Suppl):9S–23S. doi: 10.1177/0272989X17700624

Table 5.

Estimates of Hazards of Death from Breast Cancer by Treatment Modality and Stage - Example for ER+/HER2+

CMF CMF + H A+Tax+ H CMF+Tras A+Tras CMF+H+Tras A+Tax+H+Tras
Stage 0–III 0.847 0.593 0.469 0.661 0.599 0.462 0.366
Stage IV 1.0 1.0 1.0 1.0 0.8 0.8 0.8

CMF= Cyclophosphamide, Methotrexate, Fluorouracil; A= Anthracycline based; Tax=Taxane; H=Tamoxifen and/or Aromatase Inhibitor (AI) (the efficacy is assumed to be equal); Tras=Trastuzumab